Bringing an orphan drug to market By / On July 1, 2022 / At 12:22 pm / In Chemical world 13 Views Eiger picks CordenPharma to make lonafarnib, the first drug for progeria, an ultrarare premature aging disease Post navigation Prev PostSetting up to deliver a therapy for ALS Next PostFrom a shark to a possible Parkinson’s drug You May Also Like Combining expertise to develop remote-controlled nanomaterials On August 12, 2022 | In Chemical world Taking the foundation course route On August 12, 2022 | In Chemical world Dow wants small nuclear reactors to power US plant On August 11, 2022 | In Chemical world